Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991-2016.


Journal

European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595

Informations de publication

Date de publication:
08 2023
Historique:
revised: 22 06 2023
received: 04 02 2023
accepted: 26 06 2023
medline: 31 8 2023
pubmed: 4 7 2023
entrez: 4 7 2023
Statut: ppublish

Résumé

Mortality from acute myocardial infarction (AMI) has declined, increasing the pool of survivors at risk of later development of heart failure (HF). However, coronary reperfusion limits infarct size and secondary prevention therapies have improved. In light of these competing influences, we examined long-term trends in the risk of HF hospitalization (HFH) following a first AMI occurring in Scotland over 25 years. All patients in Scotland discharged alive after a first AMI between 1991 and 2015 were followed until a first HFH or death until the end of 2016 (minimum follow-up 1 year, maximum 26 years). A total of 175 672 people with no prior history of HF were discharged alive after a first AMI during the period of study. A total of 21 445 (12.2%) patients had a first HFH during a median follow-up of 6.7 years. Incidence of HFH (per 1000 person-years) at 1 year following discharge from a first AMI decreased from 59.3 (95% confidence interval [CI] 54.2-64.7) in 1991 to 31.3 (95% CI 27.3-35.8) in 2015, with consistent trends seen for HF occurring within 5 and 10 years. Accounting for the competing risk of death, the adjusted risk of HFH at 1 year after discharge decreased by 53% (95% CI 45-60%), with similar decreases at 5 and 10 years. The incidence of HFH following AMI in Scotland has decreased since 1991. These trends suggest that better treatment of AMI and secondary prevention are having an impact on the risk of HF at a population level.

Identifiants

pubmed: 37401485
doi: 10.1002/ejhf.2965
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1213-1224

Subventions

Organisme : British Heart Foundation
ID : FS/18/14/33330
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/18/6/34217
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Circulation. 2010 Feb 23;121(7):863-9
pubmed: 20142444
J Card Fail. 2022 Apr;28(4):531-539
pubmed: 34624511
J Am Heart Assoc. 2015 Jul 14;4(7):
pubmed: 26175358
Stat Med. 2000 Feb 15;19(3):335-51
pubmed: 10649300
Circ Cardiovasc Qual Outcomes. 2010 Jan;3(1):82-92
pubmed: 20123674
Circulation. 2016 Mar 1;133(9):916-47
pubmed: 26811316
Am J Cardiol. 2010 Nov 15;106(10):1382-8
pubmed: 21059425
Eur J Heart Fail. 2015 Mar;17(3):301-12
pubmed: 25655011
Lancet. 2018 Feb 10;391(10120):572-580
pubmed: 29174292
Eur Heart J Qual Care Clin Outcomes. 2023 Apr 26;9(3):268-280
pubmed: 36036480
Eur J Heart Fail. 2011 Feb;13(2):135-41
pubmed: 21118860
JACC Heart Fail. 2015 Mar;3(3):234-42
pubmed: 25742760
Circ Heart Fail. 2016 Jan;9(1):e002460
pubmed: 26699392
N Engl J Med. 2020 Jul 2;383(1):88-89
pubmed: 32343497
N Engl J Med. 2009 Sep 10;361(11):1045-57
pubmed: 19717846
Heart. 2018 Apr;104(7):600-605
pubmed: 28982720
N Engl J Med. 2017 Jul 6;377(1):41-51
pubmed: 28679089
Am Heart J. 2011 Oct;162(4):663-70
pubmed: 21982658
JACC Heart Fail. 2015 Aug;3(8):603-14
pubmed: 26251086
BMJ Open. 2018 Mar 3;8(3):e018331
pubmed: 29502083
Circulation. 2008 Nov 11;118(20):2057-62
pubmed: 18955667
Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):216-23
pubmed: 18391651
N Engl J Med. 2021 Nov 11;385(20):1845-1855
pubmed: 34758252
Circulation. 2005 Jun 28;111(25):3411-9
pubmed: 15967846
Eur Heart J. 2012 Feb;33(4):515-22
pubmed: 22096090
Lancet. 2005 Oct 8;366(9493):1267-78
pubmed: 16214597
Eur Heart J Acute Cardiovasc Care. 2017 Oct;6(7):610-622
pubmed: 27485141
Circulation. 2022 Jan 4;145(1):87-89
pubmed: 34797725
Am J Cardiol. 2018 Jul 1;122(1):1-5
pubmed: 29685572
Eur J Heart Fail. 2022 Oct;24(10):1918-1927
pubmed: 36054480
N Engl J Med. 2020 Aug 13;383(7):691-693
pubmed: 32427432
Am Heart J. 2008 Nov;156(5):810-5
pubmed: 19061692
Int J Cardiol. 2017 Dec 1;248:221-226
pubmed: 28579167
Eur Heart J. 2022 Nov 1;43(41):4421-4432
pubmed: 36036746
Eur Heart J. 2013 Oct;34(39):3017-27
pubmed: 23801825
J Am Coll Cardiol. 2009 Jan 6;53(1):13-20
pubmed: 19118718
Eur Heart J. 2018 Nov 7;39(42):3766-3776
pubmed: 30239671
J Am Heart Assoc. 2018 Dec 18;7(24):e010394
pubmed: 30514137
Circulation. 2013 Dec 17;128(24):2577-84
pubmed: 24190958
Lancet Digit Health. 2022 Jan;4(1):e37-e45
pubmed: 34952674
Eur Heart J. 2017 Nov 01;38(41):3056-3065
pubmed: 29020314
Heart. 2019 Apr;105(7):516-523
pubmed: 30470725
Am J Cardiol. 2014 May 15;113(10):1606-10
pubmed: 24666616
Curr Probl Cardiol. 2023 Aug;48(8):101215
pubmed: 35460680
JAMA Cardiol. 2022 Oct 1;7(10):1067-1075
pubmed: 36044233
Circulation. 2004 Jan 20;109(2):201-6
pubmed: 14707020
Eur Heart J. 2008 Mar;29(6):748-56
pubmed: 18308687
Open Heart. 2015 Feb 06;2(1):e000165
pubmed: 25685362
J Am Heart Assoc. 2014 Jul 28;3(4):
pubmed: 25074695
Circulation. 1994 Jan;89(1):68-75
pubmed: 8281697
Eur Heart J. 2007 Oct;28(20):2525-38
pubmed: 17951287
Health Bull (Edinb). 1993 Mar;51(2):72-9
pubmed: 8514493
Int J Cardiol. 2022 Apr 1;352:100-101
pubmed: 35134444
Lancet. 2000 May 6;355(9215):1575-81
pubmed: 10821360
Eur Heart J. 2007 Nov;28(22):2706-13
pubmed: 17901079
Eur J Prev Cardiol. 2017 Jun;24(9):971-980
pubmed: 28436728
J Clin Epidemiol. 1995 Dec;48(12):1441-52
pubmed: 8543958
J Am Heart Assoc. 2013 Oct 08;2(5):e000172
pubmed: 24103569
Int J Cardiol. 2022 Feb 1;348:147-151
pubmed: 34921898
Am Heart J. 2003 Sep;146(3):446-52
pubmed: 12947361

Auteurs

Kieran F Docherty (KF)

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

Alice M Jackson (AM)

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

Mark Macartney (M)

Public Health Scotland, Edinburgh, UK.

Ross T Campbell (RT)

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

Mark C Petrie (MC)

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

Marc A Pfeffer (MA)

Cardiovascular Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.

John J V McMurray (JJV)

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

Pardeep S Jhund (PS)

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH